imatinib mesylate has been researched along with Jaundice, Cholestatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onoe, S; Sakamoto, Y | 1 |
| Al Sobhi, E; Zahrani, Z; Zevallos, E; Zuraiki, A | 1 |
| Al Bahar, S; Pandita, R; Prakash, A; Ramamoorthy, SK; Ramaswamy, NV | 1 |
3 other study(ies) available for imatinib mesylate and Jaundice, Cholestatic
| Article | Year |
|---|---|
A case of hepatic metastasis from gastric GIST successfully resected following neoadjuvant targeted therapy.
Topics: Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Jaundice, Obstructive; Liver Neoplasms; Molecular Targeted Therapy; Neoadjuvant Therapy; Piperazines; Pyrimidines; Stomach Neoplasms | 2011 |
Imatinib-induced immune hepatitis: case report and literature review.
Topics: Adolescent; Alanine Transaminase; Antibodies, Antinuclear; Antibody Specificity; Antineoplastic Agents; Aspartate Aminotransferases; Autoantibodies; Autoantigens; Benzamides; DNA; Female; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Immunosuppressive Agents; Jaundice, Obstructive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Muscle, Smooth; Piperazines; Prednisolone; Pyrimidines | 2007 |
Safety of imatinib in chronic myeloid leukemia in blastic crisis presenting as cholestatic jaundice.
Topics: Adult; Antineoplastic Agents; Benzamides; Blast Crisis; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Humans; Imatinib Mesylate; Jaundice, Obstructive; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Male; Piperazines; Pyrimidines | 2007 |